This is a preview of subscription content, log in via an institution to check access.
REFERENCE
de Lima Lopes Jr G, Gluck S.Health economics in the Journal of Clinical Oncology and an evaluation of the indirect costs and benefits associated with adjuvant trastuzumab. Journal of Clinical Oncology 25: 3382-3383, No. 22, 1 Aug 2007
Rights and permissions
About this article
Cite this article
Indirect costs and benefits of adjuvant trastuzumab evaluated. Pharmacoecon. Outcomes News 535, 3 (2007). https://doi.org/10.2165/00151234-200705350-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705350-00004